Atlas Trials

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

Clinical trial NCT02839642 · COMPLETED

Trial details

NCT number
NCT02839642
Sponsor
Assistance Publique Hopitaux De Marseille
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Progressive Supranuclear Palsy (PSP)
Start date
2016-07-26
Primary completion
2022-06-03
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.